SWOG clinical trial number
SWOG-9518

Phase II Trial of Continuous Topotecan Infusion in Patients with Advanced Soft Tissue Sarcomas

Closed
Phase
Accrual
55%
Published
Abbreviated Title
Phase II Trial of Continuous Topotecan Infusion in Patients with Advanced Soft Tissue Sarcomas
Activated
04/01/1996
Closed
10/15/1997

Research committees

Sarcoma

Publication Information Expand/Collapse

2002

Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study

GT Budd;C Rankin;LF Hutchins;L Wong;PJ Petruska;K Antman Investigational New Drugs 20:129-132

1998

SWOG 9518: Phase II trial of continuous infusion topotecan in patients (pts) with advanced soft tissue sarcomas (sts).

C Rankin;GT Budd;L Hutchins;K Antman Proc of the American Society of Clinical Oncology 17:523a(#2011)